Results 1 to 10 of about 23,938 (205)

Advanced Glycation End Products (AGEs) Webinar Meeting Report. [PDF]

open access: greenJ Diabetes Sci Technol
The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and
Ho CN   +8 more
europepmc   +5 more sources

Advanced Glycation End-Products in Skeletal Muscle Aging [PDF]

open access: goldBioengineering, 2021
Advanced age causes skeletal muscle to undergo deleterious changes including muscle atrophy, fast-to-slow muscle fiber transition, and an increase in collagenous material that culminates in the age-dependent muscle wasting disease known as sarcopenia. Advanced glycation end-products (AGEs) non-enzymatically accumulate on the muscular collagens in old ...
Lucas C. Olson   +4 more
openalex   +5 more sources

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE) [PDF]

open access: yesCells, 2021
Systemic lupus erythematosus (SLE) is characterized by abnormal action of the immune system and a state of chronic inflammation. The disease can cause life-threatening complications.
Agnieszka Nowak   +5 more
doaj   +2 more sources

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs [PDF]

open access: yesCells, 2022
Advanced glycation end-products (AGEs) constitute a non-homogenous, chemically diverse group of compounds formed either exogeneously or endogeneously on the course of various pathways in the human body.
Aleksandra Twarda-Clapa   +3 more
doaj   +2 more sources

Advanced glycation end products regulate the receptor of AGEs epigenetically

open access: yesFrontiers in Cell and Developmental Biology, 2023
Advanced glycation end-products (AGEs) can boost their receptor of AGE (RAGE) expression through the downstream signaling pathway to facilitate AGE–RAGE interaction. In this regulation process, the primary signaling pathways are NF-κB and STAT3. However,
Xiaoqing Wu   +4 more
doaj   +3 more sources

Acetoacetate promotes the formation of fluorescent advanced glycation end products (AGEs) [PDF]

open access: greenJournal of Biomolecular Structure and Dynamics, 2015
Acetoacetate (AA) is an important ketone body, which produces reactive oxygen species (ROS). Advanced glycation end products (AGEs) are defined as final products of glycation process whose production is influenced by the levels of ROS. The accumulation of AGEs in the body contributes to pathogenesis of many diseases including complications of diabetes,
Mousa Bohlooli   +5 more
openalex   +3 more sources

Advanced glycation end products (AGEs) activate mast cells [PDF]

open access: bronzeBritish Journal of Pharmacology, 2010
BACKGROUND AND PURPOSEAdvanced glycation endproducts (AGEs) represent one of the many types of chemical modifications that occur with age in long‐lived proteins. AGEs also accumulate in pathologies such as diabetes, cardiovascular diseases, neurodegeneration and cancer. Mast cells are major effectors of acute inflammatory responses that also contribute
Émilie Sick   +6 more
openalex   +4 more sources

Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective [PDF]

open access: yesAntioxidants
Neurodegenerative diseases such as Alzheimer’s disease (AD) are closely linked to oxidative stress and advanced glycation end products (AGEs), two interrelated processes that exacerbate neuronal damage through mitochondrial dysfunction, protein ...
Virginia Boccardi   +2 more
doaj   +2 more sources

Lens Autofluorescence Based Advanced Glycation End Products (AGEs) Measurement to Assess Risk of Osteopenia Among Individuals Under the Age of 50 [PDF]

open access: yesMedical Devices: Evidence and Research, 2022
Shaoyun Li,1,* Yuefei Li,1,* Xiyan Xu,1 Jian Shao,2 Ruifeng Xie,3 Sheng Liu,1 Li Peng,1 Jin Wang,1 Kaixin Zhou,3 Huyi Feng1 1The Fifth People’s Hospital of Chongqing, Chongqing, People’s Republic of China; 2Guangzhou Laboratory, Guangzhou, People’
Li S   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy